January 18, 2017 Mass Spectrometry PR/Corporate Product Launch

908 Devices Strengthens Life Science Leadership Team and Unveils Transformational Advancements to ZipChip

01.18.17 Life Sciences 908 Devices, a pioneer of purpose-built analytical devices for chemical and biomolecule analysis, today announced significant product enhancements for ZipChip™, an innovative system that provides high-quality separation capabilities as a front-end for mass spectrometry (MS). An integrated autosampler, built-in chip recognition intelligence and application specific assay kits are being released to radically... Read more

January 18, 2017 PR/Corporate

QIAGEN Reports Results for Fourth Quarter and Full-Year 2015

VENLO, The Netherlands, February 2, 2016 /PRNewswire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced results of operations for the fourth quarter and full-year 2015, delivering higher adjusted net sales and earnings at constant exchange rates (CER) while setting goals for accelerating growth and further innovation in 2016. “QIAGEN made significant progress in... Read more

January 18, 2017 Environ, Ag./Food & Bev

Neogen develops superior chromogenic media for Salmonella

CONTACT: Joanne McPeake, Neogen Europe Ltd., +44 (0) 1292 525 600 AYR, Scotland, 18 January, 2017 — Neogen’s Lab M has developed a unique chromogenic media that offers a superior ability to simultaneously detect numerous strains of Salmonella of concern to the food and animal feed industries, while inhibiting or minimizing other organisms. This new... Read more

January 17, 2017 Clinical Research/Diagn. Environ, Ag./Food & Bev PR/Corporate

Roka Bioscience Announces Transition of CEO Role from Paul Thomas to Mary Duseau

WARREN, N.J., Jan. 17, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens today announced the appointment of Mary Duseau as President and CEO.  Ms. Duseau succeeds Paul Thomas, the Company’s President and CEO since 2009, who will assume the... Read more

January 17, 2017 Life Science Tools M&A, Partnerships

Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc.

Takara Bio USA Holdings, Inc. completes acquisition of Rubicon Genomics, Inc. Mountain View, CA—January 18, 2017—Takara Bio USA Holdings, Inc. (“TBUSH”) announced that it has completed the acquisition of Rubicon Genomics, Inc. (“Rubicon”), Rubicon has become a wholly-owned subsidiary of TBUSH as of January 17, 2017 (US local time). Under the merger agreement executed with Rubicon,... Read more